REGN
Regeneron Pharmaceuticals IncPharmaceutical Preparations
$789.45updated Sep 18, 2026
Congressional trading profile for Regeneron Pharmaceuticals Inc (REGN), covering 14 disclosed transactions by 9 lawmakers.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Total Trades
14
Politicians Trading
9
Last Traded
Jul 7, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Aug 7, 2026 | Jul 7, 2026 | Buy | $1,001 - $15,000 | +16.74% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Buy | $1,001 - $15,000 | +7.01% |
| Julia LetlowR | Mar 12, 2026 | Feb 12, 2026 | Buy | $1,001 - $15,000 | +0.74% |
| Gilbert Ray Cisneros, Jr.D | Dec 15, 2025 | Nov 18, 2025 | Buy | $1,001 - $15,000 | +8.84% |
| Robert BresnahanR | Jun 9, 2025 | May 15, 2025 | Buy | $1,001 - $15,000 | +34.95% |
| Byron DonaldsR | May 24, 2025 | Apr 10, 2025 | Sell | $1,001 - $15,000 | +44.48% |
| Byron DonaldsR | May 24, 2025 | Apr 10, 2025 | Sell | $1,001 - $15,000 | +44.48% |
| Julie JohnsonD | May 14, 2025 | Apr 1, 2025 | Sell | $1,001 - $15,000 | +27.95% |
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Sell | $1,001 - $15,000 | +41.78% |
| Jefferson ShreveR | May 8, 2025 | Apr 7, 2025 | Sell | $15,001 - $50,000 | +37.83% |
| Robert BresnahanR | Mar 27, 2025 | Feb 25, 2025 | Sell | $1,001 - $15,000 | +9.12% |
| Julie JohnsonD | Mar 12, 2025 | Feb 12, 2025 | Sell | $1,001 - $15,000 | +18.92% |
| Julie JohnsonD | Feb 12, 2025 | Jan 15, 2025 | Buy | $1,001 - $15,000 | +12.23% |
| Josh GottheimerD | Feb 10, 2025 | Jan 24, 2025 | Sell | $1,001 - $15,000 | +16.82% |